About Us
Karen Garby
MD, RPhS
Karen Garby, MD, RPhS is an interventional radiologist with 20 years of experience. Dr. Garby received her medical degree at the Medical College of Georgia at Augusta University. She is board certified in radiology and completed her residency at the University of Missouri at Kansas City after graduating from medical school. Her Interventional Radiology Fellowship was completed at Case Western. She has multiple publications to her credit and has submitted several projects including those in the Proceedings of Neuroradiology, the Journal of Endovascular Surgery, and JVIR. She is the recipient of the Patient’s Choice Award, the On-Time Doctor Award, and Compassionate Doctor Recognition.
Dr. Garby focuses on treating central and peripheral vein disease, lymphedema, and uterine fibroids, three common conditions affecting millions of individuals annually. Dr. Garby explains, “I’m pleased to be able to provide state-of-the-art treatment for venous valve failure through a tiny incision, right in my office.” In addition, many women suffer from heavy bleeding and pain from non-cancerous fibroid tumors. Dr. Garby uses a minimally-invasive procedure that cuts off the blood supply to the tumors, resolving symptoms without the need for a hysterectomy. She finds it rewarding to help her patients feel better with less down-time. Dr. Garby is also a subject expert in venous disease and vascular ultrasound, vital to the diagnosis of arterial and venous disease. She currently sits on the committee to write exam questions for the RPhS certification national standardized test.
Dr. Garby uses her experience and state-of-the-art equipment to help patients get the symptom relief they need for a better quality of life.
Jeffrey M Braxton
MD, FACS
Jeffrey M Braxton, MD FACS is double board certified in General Surgery as well as Venous and Lymphatic Medicine, and he has more than 25 years of experience. Dr. Braxton graduated medical school at the University of Michigan School of Medicine in Ann Arbor, Michigan. Dr. Braxton completed his residency in general surgery at Rush-Presbyterian-St. Luke’s Medical Center in Chicago, Illinois.
Dr. Braxton has extensive experience in the treatment of vein disease as a co-founder of AmeriVein vein treatment clinics. Dr. Braxton moved to Arizona in 2018 and worked at Arizona Vein and Vascular prior to joining the medical team at CiC. Dr. Braxton is board certified by the American Board of Surgery, the American Board of Phlebology, and he has Hyperbaric Oxygen Supervision certification.
Areas of expertise include endovenous laser ablation, radiofrequency ablation, Venaseal, foam and cosmetic sclerotherapy, and other minimally-invasive treatments. “It’s about improving quality of life” he explains when asked about his inspiration for treating venous disease. Dr. Braxton enjoys taking the time to get to know his patients and understand their concerns. He teaches them about the disease process and how treatment can alleviate their pain.
Patients who experience tired or achy legs at the end of the day might have symptoms of chronic venous insufficiency (CVI) that can lead to serious complications. Dr. Braxton advises patients to seek treatment as soon as possible to minimize their risk. His experience gives him the insight to design individualized treatment plans that achieve the best outcome for each patient.
Dr. Braxton presented “Transilluminated Powered Phlebectomy for Varicose Veins” at the Northwestern Vascular Symposium. While not working, he enjoys time as a private pilot, scuba diver, photographer, hiker, and golfer.
Hassan Makki
DO, FACC
Hassan Makki, DO is an interventional cardiologist with more than fifteen years of experience. Dr. Makki specializes in treating cardiac and vascular conditions including the areas of heart failure, various heart diseases, atherosclerosis, high cholesterol, stroke, heart attack, and blood clots.
Dr. Makki graduated from medical school at Kirksville College of Osteopathic Medicine. He moved to Phoenix after completing his Internal Medicine Residency and Cardiology Fellowship in Michigan through the Michigan State state-wide campus program at Garden City Hospital. After spending five years treating hypertension, heart failure, coronary artery disease, and rhythm disorders through his general cardiology practice, Dr. Makki returned to the catheterization laboratory for further training. He completed an additional Interventional Fellowship at St. John’s Hospital in Macomb, Michigan where he trained in both coronary and peripheral interventions utilizing the newest techniques with the most state-of-the-art equipment.
Dr. Makki takes a personal approach to patient care, getting to know the individual so that he can treat their heart and their wellness as a whole. His use of minimally-invasive, state-of-the-art techniques allows him to diagnose and treat patients with fewer risks for complications.
“I perform more than 90% of my procedures using the Radial Approach, where we go through the wrist instead of the groin area,” Dr. Makki said. This procedure allows patients to go home sooner, often in less than two hours.
Dr. Makki believes in treating more than a patient’s symptoms in a compassionate and thoughtful manner to achieve the best outcome. He is ranked among the top 20% of doctors in the United States based on his credentials, experience, and network. He is one of this country’s most highly rated doctors.
As a part of the Limb Salvage Program at CiC, Dr. Makki’s focus is on the restoration of blood flow to the arteries of the legs to prevent lower limb amputations through advanced, minimally-invasive techniques. He believes that helping a patient avoid an amputation is as rewarding and socially relevant as any of his endeavors in treating heart disease.
As a strong proponent of preventive medicine, Dr. Makki advocates and lives a very healthy lifestyle. He believes that combining daily exercise with a diet of fresh, unaltered foods with judicious guideline-directed medication when needed is essential for living a healthy lifestyle.
James R. McEown
MD
James McEown, MD is certified by the American Board of Internal Medicine as well as the American Board of Emergency Medicine. He received his medical training at the University of Guadalajara, Mexico, followed by the Fifth Pathway program at the University of Arizona College of Medicine and his Internship and Residency at the Department of Internal Medicine at Maricopa Medical Center. He joined Comprehensive Integrated Care (CiC) in 2017 after 14 years at Morrison Vein Institute treating venous disorders. In addition to working at CiC, Dr. McEown currently works at the Emergency Department at St. Joseph’s Hospital and Medical Center. Dr. McEown is also a member of the American Vein and Lymphatic Society.
For CiC, Dr. McEown performs the following procedures: ambulatory phlebectomy (varicose vein surgery), endovenous laser and radiofrequency treatment, Medicare-approved cyanoacrylate venous ablation treatment, venous Doppler (legs), and venous sclerotherapy.
On a personal note, Dr. McEown himself has received vein treatment. This allows him an empathetic understanding of his patients’ needs when working together to advise and treat those suffering from venous disease. In his free time, Dr. McEown enjoys backpacking, hunting, hiking, and biking, and he is an avid gardener.
Ryan G. O’Hara
MD
Dr. O’Hara brings his extensive background in vascular embolization and minimally invasive treatments for tumors to Comprehensive Integrate Care Utah (CiC Utah). As an endovascular specialist, he is able to treat a variety of conditions throughout the body, with a special focus on peripheral artery disease and vein conditions. His experience with embolization technology and techniques includes innovative treatments for enlarged prostates and varicocele patients.
He received his medical training at the University of Washington in Seattle followed by training in diagnostic radiology at Sacred Heart Medical Center in Spokane, Washington. Dr. O’Hara continued with fellowship training in Vascular and Interventional Radiology at the University of Pennsylvania where he obtained a certificate of added qualification in vascular and interventional radiology.
At the University of Utah and Huntsman Cancer Center, he helped develop the Integrated Theranostics Center (ITC) with particular focus on the use of lutetium-based Peptide Receptor Radionuclide Therapy (PRRT) for the treatment of metastatic neuroendocrine tumors. Dr. O’Hara was also the Director of Interventional Oncology at the University of Utah and Huntsman Cancer Institute.
When he is not pursuing his passion of helping people live better, healthier lives, Dr. O’Hara enjoys exploring the mountains and deserts of Utah with his wife and two cool kids. He loves to tinker in his electronics/wood shop. This creative and technical experience has served him well with his work at the University of Utah Bioengineering Department, where he has helped develop solutions for a variety of medical and healthcare concerns. Several of the projects have received patents.
CiC Utah is honored to welcome Dr. O’Hara to its medical team.
Education and Training
University of Pennsylvania Health System, Fellowship
Inland Empire Hospital Service, Residency and Internship
University of Washington School of Medicine, Medical School
Certifications and Licenses
Utah State Medical License, 2010 – 2022
American Board of Radiology, Diagnostic Radiology
American Board of Radiology, Vascular and Interventional Radiology
Clinical Trials
A Phase III Randomized, Double-Blind Trial of Chemoembolization With or Without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients With and Without Vascular Invasion Start of enrollment: 2009 Oct 01(Gbenga), O.O.,Averbook, B.J.,Ballard, H.S.,Behrens, R.J.,Benson, A.B.,Brown, T.D.,Eisenberg, P.D.,Flynn, P.J.,Galanopoulos, C.A.,Gaur, R.,Gonzales-Chambers, R.,Govindarajan, R.,Kambhampati, S.,Kauh, J.S….
Professional Membership
Society of Interventional Radiology, SIR Member
Hospital Affiliations
Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah
University of Utah Health, Salt Lake City, Utah
Intellectual Property
Arm Support for Supine Patient Tim Michaelis, Talmage Barth, Michael Price, Ryan O’Hara, Holden Brown, Niki Davis (2016).
Book Chapter
O’Hara R, Oplin J, (2013). Liver Tumors. In Gaffnery DK (Ed.), Radiation Oncology: Imaging and Treatment (First Edition, p. 5:104). Salt Lake City: Amirsys.
Active Grants
January 16, 20018 – Present Y90 Application Development
Principal Investigator(s): Ryan G. O’Hara
Direct Costs: $5,000 Total Costs: $5,000
Sirtex Medical Inc.
Role: Principal Investigator
January 6, 1970 – Present Evaluation of Ablation Zone Sizing Using a MicroThermX® Microwave Ablation System in Patients with Hepatic Tumors
Principal Investigator(s): Ryan G. O’Hara
Direct Costs: $34,378 Total Costs: $45,620
BSD Medical Corporation
Role: Principal Investigator
July 1, 2016 – Present Radiation-Emiting SIR-Spheres in Non-Resectable (RESIN) Liver Tumor Patient Study
Principal Investigator(s): Ryan G. O’Hara
Direct Costs: $33,248 Total Costs: $45,383
Sirtex Medical Inc.
Role: Principal Investigator
Recently Published Abstracts (Last 3 years)
R Hardman, T. Smith, L Jenkins, Z Cizman, K Marashi, R O’Hara (2019). Retrospective
evaluation of extracellular matrix enterocutaneous fistula plugs for enteric fistula [Abstract]. Journal of Vascular and Interventional Radiology, 30(3), s139-s140.
R Hardman, G Noda, L Jenkins, J Jorgensen, R O’Hara (2016). Added value of physician extenders in an inpatient academic hospital: a retrospective review of E & M codes [Abstract]. journal of vascular and Interventional Radiology, 27(3), s214-s215.
- Besachio, R. O’Hara, B. Hamilton, R. Hardman (2018). Intraprocedural renal hilar nerve block during percutaneous renal tumor ablation: a postoperative opioid-sparing pain management technique [Abstract]. journal of vascular and interventional radiology, 29(4) s107.
- Hardman, D. Besachio, R. O’Hara, K. Marashi (2018). Renal Ablation Using a 915MHz Synchronous Wave Microwave Ablation System: Safety and Short-term Follow Up [Abstract]. Journal of Vascular and Interventional Radiology, 29(4), S1-S316.
Peer-Reviewed Journal Articles (Last 3 years)
Campsen J, Bassett M, O’Hara R, Kim R, Martinez E, Hardman R, Myers J, Hamilton B (2019). Renal hilar block predicts long-term success of renal auto-transplantation for loin pain hematuria syndrome. Int Urol Nephrol.
Keith Quencer, Anthony Tadros, Keyan Marashi, Ziga Cizman, Eric Reiner, Ryan O’Hara, Rahmi Oklu (2018). Bleeding after Percutaneous Transhepatic Biliary Drainage: Incidence, Causes, and Treatments. J Clin Med, 7(94), 1-17.
Thomas Chaly, Jeffrey Campsen, Ryan O’Hara, Rulon Hardman, Juan F Gallegos-Orozco, Heather Thiesset, Robin Kim (2017). Mucocele Mimicking a Gallbladder in a Transplanted Liver: A case report and review of the literature. World J Transplant, 7(6), 359-363.
Balch H, Crawford H, McDonald J, O’Hara R, Whitehead K (2017). Long-Term Treatment Outcomes of Embolotherapy in Pulmonary Arteriovenous Malformations in Children with Hereditary Hemorrhagic Telangiectasia. Ann Vasc Med Res, 4(4), 1064-72.
Jeffrey Campsen, Mitchell Bassett, Ryan O’Hara, Heather Thiesset, Robin Kim, Rulon Hardman, Blake Hamilton (2017). Percutaneous Renal Hilar Blockade to Predict Success of Auto Kidney Transplantation for Loin Pain Hematuria Syndrome. J Urol, 195(4), e382-e383.
Campsen J, Bassett M, O’Hara R, Rosales A, Kim R, Hardman R, Hamilton B (2017). MP30-19 1-year follow-up: percutaneous renal hilar blockade to predict success of auto kidney transplantation for loin pain hematuria syndrome. J Urol, 197(4), e397.
Jones JP, Sima M, O’Hara RG, Stewart RJ (2016). Water-Borne Endovascular Embolics Inspired by the Undersea Adhesive of Marine Sandcastle Worms. Adv Healthc Mater, 5(7), 795-801.